title: The potential of computed crystal energy landscapes to aid solid-form development.
abstract: Solid-form screening to identify all solid forms of an active pharmaceutical ingredient (API) has become increasingly important in ensuring the quality by design of pharmaceutical products and their manufacturing processes. However, despite considerable enlargement of the range of techniques that have been shown capable of producing novel solid forms, it is possible that practically important forms might not be found in the short timescales currently allowed for solid-form screening. Here, we report on the state-of-the-art use of computed crystal energy landscapes to complement pharmaceutical solid-form screening. We illustrate how crystal energy landscapes can help establish molecular-level understanding of the crystallization behavior of APIs and enhance the ability of solid-form screening to facilitate pharmaceutical development.
authors: Department of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, UK. Electronic address: s.l.price@ucl.ac.uk.
authors: Sarah L
authors: SL
authors: Price
authors: Small Molecule Design and Development, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.
authors: Susan M
authors: SM
authors: Reutzel-Edens
mesh_terms: D003460:Crystallization; D015195:Drug Design; D004364:Pharmaceutical Preparations / Q000737:chemistry*
chemical_list: D004364:Pharmaceutical Preparations